A Study to Assess Long-term Safety, Tolerability, and Efficacy of Rocatinlimab in Adult and Adolescent Participants With Moderate-to-severe Atopic Dermatitis (AD)

NCT ID: NCT05882877

This clinical trial is studying a medication called rocatinlimab to see how safe it is and how well it works for people aged 12 and older who have moderate to severe atopic dermatitis, which is a t...

Recruiting

Phase: PHASE3 Conditions: Atopic Dermatitis

A Study to Evaluate Avacopan in Participants With ANCA-associated Vasculitis

NCT ID: NCT06072482

This clinical trial is studying a medication called avacopan to see how safe it is for people with a condition known as ANCA-associated vasculitis, which causes inflammation of blood vessels. The t...

Recruiting

Phase: PHASE4 Conditions: Antineutrophil Cytoplasmic Antibody-associated Vasculitis

LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis

NCT ID: NCT06632444

The LIVERAGE™ clinical trial is studying a medication called survodutide to see if it can help adults with a liver disease known as Metabolic Dysfunction Associated Steatohepatitis (MASH) who also ...

Recruiting

Phase: PHASE3 Conditions: Liver Fibrosis, Metabolic Dysfunction Associated Steatohepatitis (MASH)

LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis

NCT ID: NCT06632457

The LIVERAGE™ study is researching whether a medication called survodutide can help adults with a liver disease known as non-alcoholic steatohepatitis (NASH) or metabolic-associated steatohepatitis...

Recruiting

Phase: PHASE3 Conditions: Metabolic Dysfunction Associated Steatohepatitis

Hypo-fractionated Radiation Therapy With or Without Androgen Suppression for Intermediate Risk Prostate Cancer

NCT ID: NCT01492972

This clinical trial is examining two different treatment approaches for men with intermediate risk prostate cancer. Researchers want to find out how effective and safe hypofractionated proton beam ...

Recruiting

Phase: PHASE3 Conditions: Prostate Cancer

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

NCT ID: NCT03866382

This clinical trial is investigating how well three medications—cabozantinib, nivolumab, and ipilimumab—work together to treat patients with rare genitourinary tumors that have spread to other part...

Recruiting

Phase: PHASE2 Conditions: Stage IVB Prostate Cancer AJCC v8, Stage IV Renal Cell Cancer AJCC v8 +43 more

Testing the Addition of Radiation Therapy to the Usual Immune Therapy Treatment (Atezolizumab) for Extensive Stage Small Cell Lung Cancer, The RAPTOR Trial

NCT ID: NCT04402788

The RAPTOR Trial is a clinical study looking at whether adding radiation therapy to the usual treatment with atezolizumab can help patients with extensive stage small cell lung cancer. This type of...

Recruiting

Phase: PHASE2 Conditions: Extensive Stage Lung Small Cell Carcinoma

Randomized Study in Children and Adolescents With Migraine: Acute Treatment

NCT ID: NCT04649242

This clinical trial is looking at a new treatment called BHV-3000 for children and teenagers who suffer from moderate or severe migraines. The study aims to see if this medication is safe and effec...

Recruiting

Phase: PHASE3 Conditions: Pediatric Migraine

Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine

NCT ID: NCT04743141

This clinical trial is studying the long-term safety of a medication called rimegepant for treating migraines in children and teenagers aged 6 to 17 years old. The goal is to see how well rimegepan...

Recruiting

Phase: PHASE3 Conditions: Acute Treatment of Migraine

LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve

NCT ID: NCT04752722

The LEGEND Study is a clinical trial that is investigating a new treatment called EG-70 for patients with a type of bladder cancer known as non-muscle invasive bladder cancer (NMIBC). Specifically,...

Recruiting

Phase: PHASE1 Conditions: Superficial Bladder Cancer, Non-muscle Invasive Bladder Cancer With Carcinoma in Situ

Program to Assess Adverse Events and Change in Disease Activity of Oral Upadacitinib in Adult Participants With Moderate to Severe Systemic Lupus Erythematosus

NCT ID: NCT05843643

This clinical trial is studying the safety and effectiveness of a medication called upadacitinib for adults with moderate to severe systemic lupus erythematosus (SLE), a disease that causes inflamm...

Recruiting

Phase: PHASE3 Conditions: Systemic Lupus Erythematosus

A Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib in Adult and Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa Who Have Failed Anti-TNF Therapy

NCT ID: NCT05889182

This clinical trial is studying a medication called upadacitinib to see how effective and safe it is for treating moderate to severe hidradenitis suppurativa (HS) in adults and adolescents who have...

Recruiting

Phase: PHASE3 Conditions: Hidradenitis Suppurativa

Nectero EAST System Clinical Study

NCT ID: NCT06001918

The Nectero EAST System Clinical Study is a research trial aimed at helping patients with small to mid-sized abdominal aortic aneurysms (AAAs), which are bulges in a major blood vessel in the abdom...

Recruiting

Phase: PHASE2 Conditions: Abdominal Aortic Aneurysm

A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events

NCT ID: NCT06112418

The TRANSFORM trial is a research study designed to compare two different approaches to help prevent heart problems in people who are at higher risk but do not currently have any symptoms of heart ...

Recruiting

Phase: NA Conditions: Diabetes Mellitus, Type 2, Metabolic Syndrome +1 more

A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)

NCT ID: NCT06585787

The ADEPT-4 clinical trial is studying a new treatment called KarXT for individuals with Alzheimer's Disease (AD) who are experiencing psychosis, which includes symptoms like hallucinations or delu...

Recruiting

Phase: PHASE3 Conditions: Alzheimer Disease

Open-Label Extension Study of Setmelanotide

NCT ID: NCT06596135

This is an open-label extension study of setmelanotide (also called RM-493 or Imcivree) to see how safe and tolerable it is to continue this treatment over the long term in people 2 years and older...

Enrolling by invitation

Phase: PHASE3 Conditions: Obesity Associated With Defects in Leptin-melanocortin Pathway

A Study to Test Whether BI 771716 Helps People With an Advanced Form of Age-related Macular Degeneration (AMD) Called Geographic Atrophy

NCT ID: NCT06722157

This clinical trial is investigating a new treatment called BI 771716 for people aged 50 and older who have an advanced eye condition known as geographic atrophy, which is a type of age-related mac...

Recruiting

Phase: PHASE2 Conditions: Geographic Atrophy, Macular Degeneration, Age-related

A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1)

NCT ID: NCT07011732

The ADAGIO-1 clinical trial is a study looking at a new treatment called KarXT combined with KarX-EC for adults experiencing agitation due to Alzheimer’s disease. Agitation can include feelings of ...

Recruiting

Phase: PHASE3 Conditions: Alzheimer Disease

Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)

NCT ID: NCT05579366

This clinical trial is investigating a new drug called PRO1184 for patients with various types of advanced solid tumors, including different forms of ovarian, lung, and breast cancer. The main goal...

Recruiting

Phase: PHASE1 Conditions: Non-small Cell Lung Cancer, Endometrial Cancer +13 more

A Study Evaluating the Safety, Pharmacokinetics, and Activity of RO7656594 In Participants With Advanced or Metastatic Prostate Cancer

NCT ID: NCT05800665

This clinical trial is studying a new drug called RO7656594 to see how safe it is and how well it works for men with advanced or metastatic prostate cancer, which means the cancer has spread beyond...

Recruiting

Phase: PHASE1 Conditions: Metastatic Prostate Cancer, Advanced Prostate Cancer

Main Menu

Clinical Trials in Scottsdale, Arizona

434 Active Trials Found in Scottsdale

A Study to Assess Long-term Safety, Tolerability, and Efficacy of Rocatinlimab in Adult and Adolescent Participants With Moderate-to-severe Atopic Dermatitis (AD)

A Study to Evaluate Avacopan in Participants With ANCA-associated Vasculitis

LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis

LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis

Hypo-fractionated Radiation Therapy With or Without Androgen Suppression for Intermediate Risk Prostate Cancer

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

Testing the Addition of Radiation Therapy to the Usual Immune Therapy Treatment (Atezolizumab) for Extensive Stage Small Cell Lung Cancer, The RAPTOR Trial

Randomized Study in Children and Adolescents With Migraine: Acute Treatment

Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine

LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve

Program to Assess Adverse Events and Change in Disease Activity of Oral Upadacitinib in Adult Participants With Moderate to Severe Systemic Lupus Erythematosus

A Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib in Adult and Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa Who Have Failed Anti-TNF Therapy

Nectero EAST System Clinical Study

A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events

A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)

Open-Label Extension Study of Setmelanotide

A Study to Test Whether BI 771716 Helps People With an Advanced Form of Age-related Macular Degeneration (AMD) Called Geographic Atrophy

A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1)

Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)

A Study Evaluating the Safety, Pharmacokinetics, and Activity of RO7656594 In Participants With Advanced or Metastatic Prostate Cancer